首页 | 本学科首页   官方微博 | 高级检索  
     


Absence of motilin gene mutations in infantile hypertrophic pyloric stenosis
Authors:Svenningsson Anna  Lagerstedt Kristina  Omrani Mir Davood  Nordenskjöld Agneta
Affiliation:a Department of Molecular Medicine and Surgery, Karolinska Institutet, 171 76 Stockholm, Sweden
b Division of Pediatric Surgery, Astrid Lindgren's Hospital, Karolinska University Hospital, 171 76 Stockholm, Sweden
Abstract:

Background

Erythromycin treatment before 2 weeks of age has been shown to increase the risk of infantile hypertrophic pyloric stenosis (IHPS) up to 10 times. Erythromycin is a motilin agonist, a hormone that induces gastrointestinal contractions. The purpose of this study was to investigate if mutations in the motilin gene (MLN) cause IHPS or if the V15A polymorphism in MLN is associated with the disease.

Methods

The MLN was screened for mutations, and the V15A polymorphism was determined in a total of 57 patients with IHPS using polymerase chain reaction and DNA sequencing. The polymorphism genotype and allele frequencies among the patients were compared with 184 controls.

Results

We detected 3 different, not previously reported, MLN sequence variants in 4 patients. One of these variants results in an amino acid exchange in the motilin signal peptide (A25G). All 3 detected sequence variants were also found in controls or were not inherited with the disease. We found no significant association between the V15A polymorphism and the disease.

Conclusions

We have excluded the MLN coding region as a major cause of IHPS. Future studies will evaluate the importance of this metabolic pathway in the pathogenesis of IHPS.
Keywords:Erythromycin   Infantile hypertrophic pyloric stenosis   Motilin   V15A polymorphism
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号